Related references
Note: Only part of the references are listed.Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia
Y. Tanaka et al.
PHARMACOGENOMICS JOURNAL (2015)
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms
Antonio D'Avolio et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
ABCG2 DYSFUNCTION INCREASES SERUM URIC ACID BY DECREASED INTESTINAL URATE EXCRETION
Tappei Takada et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2014)
The Effect of ABCG2 Genotype on the Population Pharmacokinetics of Sunitinib in Patients With Renal Cell Carcinoma
Tomoyuki Mizuno et al.
THERAPEUTIC DRUG MONITORING (2014)
The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia
Dietrich Keppler
DRUG METABOLISM AND DISPOSITION (2014)
Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
Kenta Yoshida et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer
Masahide Fukudo et al.
CLINICAL PHARMACOKINETICS (2013)
Transporters in Drug Development and Clinical Pharmacology
K. M. Giacomini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
K. M. Hillgren et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
K. M. Giacomini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease
Sarah A. Ingersoll et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Understanding the Critical Disposition Pathways of Statins to Assess Drug-Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
R. Elsby et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Functional Significance of Genetic Polymorphisms in P-glycoprotein (MDR1, ABCB1) and Breast Cancer Resistance Protein (BCRP, ABCG2)
Ichiro Ieiri
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Impact of Genetic Variation in Breast Cancer Resistance Protein (BCRP/ABCG2) on Sunitinib Pharmacokinetics
Tomoyuki Mizuno et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease?
Elias Zintzaras
INFLAMMATORY BOWEL DISEASES (2012)
The bile salt export pump (BSEP) in health and disease
Ralf Kubitz et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
The PepT1-NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Guillaume Dalmasso et al.
GASTROENTEROLOGY (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients in the Chronic Phase
Naoto Takahashi et al.
PHARMACOLOGY (2011)
ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma
T. Mizuno et al.
ANNALS OF ONCOLOGY (2010)
The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men
Fabiana B. Kohlrausch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction The GEOSTAT-1 Study
Kristian M. Bailey et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship With Gout and Cardiovascular Disease Risk Factors
Qiong Yang et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
B. Tomlinson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease
Hiromistu Ban et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration
Kimberly K. Adkison et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
ABCG2: A perspective
Robert W. Robey et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients
Kacper A. Wojtal et al.
DRUG METABOLISM AND DISPOSITION (2009)
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma
Fabienne Thomas et al.
EUROPEAN JOURNAL OF CANCER (2009)
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
Lisa R. Trevin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
Tomoka Furukawa et al.
PHARMACEUTICAL RESEARCH (2009)
Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simastatin
Jenni E. Keskitalo et al.
PHARMACOGENOMICS (2009)
Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans
Y. Yamasaki et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
Abbas Dehghan et al.
LANCET (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Breast cancer resistance protein (ABCG2) and drug disposition:: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
Bradley L. Urquhart et al.
PHARMACOGENETICS AND GENOMICS (2008)
Variability in human hepatic MRP4 expression: influence of cholestasis and genotype
U. Gradhand et al.
PHARMACOGENOMICS JOURNAL (2008)
ABCG2: structure, function and role in drug response
Orsolya Polgar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia
Chunying Li et al.
CELL (2007)
Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk
Antonius E. van Herwaarden et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The apical conjugate efflux pump ABCC2 (MRP2)
Anne T. Nies et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Genetics of the innate immune response in inflammatory bowel disease
Johan Van Limbergen et al.
INFLAMMATORY BOWEL DISEASES (2007)
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Role of BCRP 421C>A polymorphism on rosuvastatin pharynacokinetics in healthy Chinese males
Wei Zhang et al.
CLINICA CHIMICA ACTA (2006)
Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins
Roger G. Deeley et al.
PHYSIOLOGICAL REVIEWS (2006)
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides
N Zelcer et al.
JOURNAL OF HEPATOLOGY (2006)
Cyclosporine markedly raises the plasma concentrations of repaglinide
LI Kajosaari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression
B Chowbay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5)
CA Ritter et al.
DRUG METABOLISM REVIEWS (2005)
Peptide transporters: Structure, function, regulation and application for drug delivery
T Terada et al.
CURRENT DRUG METABOLISM (2004)
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins - Introduction
MA Hediger et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
hPepT1 transports muramyl dipeptide, activating NF-κB and stimulating IL-8 secretion in human colonic Caco2/bbe cells
SR Vavricka et al.
GASTROENTEROLOGY (2004)
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane
M Rius et al.
HEPATOLOGY (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
The superfamily of organic anion transporting polypeptides
B Hagenbuch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria
JW Jonker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tissue distribution and induction of human multidrug resistant protein 3
GL Scheffer et al.
LABORATORY INVESTIGATION (2002)
Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus
N Ichimaru et al.
ATHEROSCLEROSIS (2001)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver
MG Donner et al.
HEPATOLOGY (2001)
Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: Transport of bacterial peptides influences expression of MHC class 1 molecules
D Merlin et al.
GASTROENTEROLOGY (2001)
Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation
T Hashida et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family
I Tamai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)
T Hirohashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
